Sino Biopharm Strikes Drug Licensing Deal With AstraZeneca, Deepens GSK Partnership
Sino Biopharm Strikes Drug Licensing Deal With AstraZeneca, Deepens GSK Partnership
Sino Biopharmaceutical will receive $200 million upfront from AstraZeneca, and will be eligible for milestone payments.
White House Pressures Top U.S. Grocers on Beef Prices
An Agriculture Department official spoke last week with grocers including Walmart, Kroger and Albertsons, according to people familiar with the matter.
GM-Backed Momenta Makes Muted Hong Kong Debut After $751 Million IPO
Coty to Transfer Gucci Beauty License Back to Kering Ahead of Schedule for $400 Million
Coty to Transfer Gucci Beauty License Back to Kering Ahead of Schedule for $400 Million
Walmart Lowers Prices on Thousands of Items, Including Beef and Coca-Cola
The U.K. drugmakers added to a series of recent tie-ups with Chinese counterparts amid broader scrutiny of such transactions in…
The China question, FDA leadership shakeups, and other biotech news from The Readout
"We are working with the government and trying to find constructive solutions so that Americans pay less for their medicines."
AstraZeneca, GSK intensify China ties with Sino Biopharm deals
Fierce Pharma Asia—More AZ China deals; Kailera, Hengrui’s oral GLP-1 data; Scrutiny of Chinese trials
A $10B deal, China trial scrutiny and highlights from ADA 2026
Prime wins Beam arbitration, clearing path to clinic
Sino Biopharmaceutical fecha acordo bilionário com a AstraZeneca e expande parceria com a GSK
Sino Biopharm hooks AstraZeneca, GSK for separate respiratory partnerships
